WiQo is the result of a pioneering experience in the field of aesthetic medicine and since January 2023 is backed by Archimed, a French Investement Fund specialized in Healthcare. All WiQo products are born from a long clinical experience and from a dermatological attention to skin care. They are produced in Italy, marketed in more than 55 countries around the world and presented at the most important international conferences and on influential industry magazines. Over 40,000 dermatologists, aesthetic doctors and professionals have chosen WiQo for their clinic. Since 2011, over 6 million professional treatments with PRX-T33 were performed.